1 / 5

Molecular Scissors Genome Editing Market Size, Shares and Growth Opportunities Forecasts Till 2025

Application of technology in the therapeutic genetic editing process of infected tissue and cells eliminates damage causing mutations, which is expected to enlarge the market size.

Akashchopda
Download Presentation

Molecular Scissors Genome Editing Market Size, Shares and Growth Opportunities Forecasts Till 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Scissors/Genome Editing Market Size, Shares and Growth Opportunities Forecasts Till 2025 “The Global Molecular Scissors/ Genome Editing Market is estimated to develop at a substantial CAGR for the duration of the prediction period. The market research report delivers an exceptional means for assessing the market, emphasizing openings, and backing up the planned and calculated policymaking.” Industry Insights The Global Molecular Scissors/ Genome Editing Market size was worth USD 2,585.5 million in 2016 which is anticipated to grow at a CAGR of more than 13.5% during the forecast period. Application of technology in the therapeutic genetic editing process of infected tissue and cells eliminates damage causing mutations, which is expected to enlarge the market size. The existence of robust pipeline products is anticipated to influence progress in genomics sector over the projected period. Innovative products support the DNA targeting advances with simplicity of AAV packaging for distribution, specificity of the nuclease, and improved flexibility. Furthermore, genome editing is an upcoming stream and biotech & pharmaceutical companies are collaborating for the enhancement of technology. Several companies are also involved in product manufacturing either on their own or by the asset of strategic partners. However, factors such as IP disputes in context with CRISPR technology and off-target toxicity issues are anticipated to restrain sector growth. Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/molecular-scissors-genome-editing-market/request-sample

  2. Technology Insights Several technologies such as TALENs/MegaTALs, ZFN, and CRISPR are the latest technologies which are applicable in the genome editing field. Other methods such as Jump-In, Flp-In, PiggyBac, and antisense are applicable for genome engineering. The largest portion was accounted by CRISPR and is anticipated to rule the industry over the forecast period. Upcoming advancements in this segment is expected to support in the projected growth in the coming years. Delivery Method Insights The largest share was accounted by the ex-vivo procedure as DNA modification can be controlled easily by this method of delivery. Additionally, the duration and strength of nuclease expression can be controlled to abate off-targeting excision and maximize efficacy. CAR-t tool which is applicable in the treatment of blood cancer as ex-vivo product is highlighted in the pipeline of therapeutic molecular scissors. Moreover, several diseases need an in-vivo method of treatment since some particular cells cannot be eliminated from the body. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/molecular-scissors-genome-editing-market Application Insights The largest market share was accounted by gene therapy and stem cell therapy and is expected to maintain its dominance in the coming years. Application of innovative technology for the development of novel molecules that can eradicate infectious diseases and hematological malignancies are anticipated to promote the approval of this technology over the forecast period. End-use Insights The largest share was attributed by biotechnology organizations as an enormous amount of research is undergoing for development of innovative therapeutics by virtue of molecular scissors. The fastest growth is accounted by government and academic research institutes in the coming years as the adoption rate is increasing for genome engineering technology. Moreover, improvement in genome engineering techniques is expected to quicken its application in research schemes by the government.

  3. Service Insights Key market players offer partial services and user-friendly sets to the stem cell scientists which assist them to perform the engineering process without compromising the required pluripotency conditions. Companies, such as Sigma-Aldrich Corporation and Thermo Fisher offer customized products for cutting the cell lines at specific points, thereby boosting the growth contract based genome editing field. Regional Insights The market was dominated by North America owing to rising adoption of innovative and improved technologies in the U.S. Moreover, higher occurrence rate of monogenic disorders is also accountable for the estimated share. For instance, cystic fibrosis befalls at an occurrence of 1 in 2,500 deliveries in the U.S thereby resulting in lung and other organ damage. Furthermore, recently 1, 22,000 individuals necessitate organ transplant which is gradually growing and anticipated to boost growth in the coming years. Asia Pacific is anticipated to witness substantial progress over the forecast period due to rising research in personalized medicine in this sector. Competitive Insights Key market entities include Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, Editas Medicine, Sangamo, Intellia Therapeutics Inc., CRISPR THERAPEUTICS and Caribou Biosciences Inc. Some companies are taking benefit of authorizations from universities for the DNA editing tools application. These participants are involved in various approaches such as cross-linking agreements, acquisitions, and in- house research which permit the novel intellectual property licensing of innovative proteins. Market Segment Technology Outlook (Revenue, USD Million; 2014 - 2025) • (CRISPR)/Cas9 • TALENs/MegaTALs • ZFN • Others Delivery Method Outlook (Revenue, USD Million; 2014 - 2025)

  4. • Ex-Vivo • In-Vivo Application Outlook (Revenue, USD Million; 2014 - 2025) • Cell Line Engineering/ Gene Therapy • Animal Genetic Engineering • Plant Genetic Engineering • Other Applications End-use Outlook (Revenue, USD Million; 2014 - 2025) • Biotechnology & Pharmaceutical Companies • Academic & Government Research Institutes • Contract Research Organizations Service Outlook (Revenue, USD Million, 2014 - 2025) • Contract • In-house Regional Outlook (Revenue, USD Million; 2013 - 2025) • North America • U.S. • Canada • Europe • Germany • UK • Asia Pacific • Japan • China • Latin America • Brazil • Middle East and Africa (MEA) • South Africa See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology

  5. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184

More Related